Kerala Ayurveda [KERALAYUR] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kerala Ayurveda Ltd. wins in 5 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kerala Ayurveda Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 617.16 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 39.17 10.82 Divi's Laboratories Ltd.
Debt-to-Equity Ratio 938.32 0.58 Divi's Laboratories Ltd.
PEG Ratio 11.48 4.63 Divi's Laboratories Ltd.
EV/EBITDA -15.24 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) -18.52% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) -8.08% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) N/A 29.65% N/A
Return on Equity 140.14% 14.64% Kerala Ayurveda Ltd.
Return on Assets (TTM) -10.84% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-84.95M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -53.05% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 2.49 16.18 Kerala Ayurveda Ltd.
Enterprise Value $3.73B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 2.93 15.86 Kerala Ayurveda Ltd.
Gross Profit Margin (TTM) 87.04% 63.71% Kerala Ayurveda Ltd.
Revenue per Share (TTM) $105 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $-19.60 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.08 0.19 Kerala Ayurveda Ltd.

Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kerala Ayurveda Ltd.-2.98%-14.09%-15.84%-20.57%-50.84%-46.37%
Divi's Laboratories Ltd.0.30%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kerala Ayurveda Ltd.-53.05%64.05%238.54%225.21%225.76%263.24%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.

MetricKERALAYURDIVISLAB
Market Information
Market Cap i₹3.10B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i11,583253,443
90 Day Avg. Volume i41,986283,911
Last Close₹169.55₹6,596.50
52 Week Range₹150.00 - ₹625.00₹5,636.50 - ₹7,071.50
% from 52W High-72.87%-6.72%
All-Time High₹625.00 (Jul 01, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-72.87%-6.72%
Growth Metrics
Quarterly Revenue Growth0.06%0.12%
Quarterly Earnings Growth0.06%-0.01%
Financial Health
Profit Margin (TTM) i-0.19%0.24%
Operating Margin (TTM) i-0.08%0.30%
Return on Equity (TTM) i1.40%0.15%
Debt to Equity (MRQ) i938.320.58
Cash & Liquidity
Book Value per Share (MRQ)₹6.23₹580.95
Cash per Share (MRQ)₹4.08₹122.95
Operating Cash Flow (TTM) i₹43.75M₹19.67B
Levered Free Cash Flow (TTM) i₹-139,590,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.

MetricKERALAYUR (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i617.1667.11
Forward P/E iN/A53.75
PEG Ratio i11.484.63
Price to Sales (TTM) i2.4916.18
Price to Book (MRQ) i39.1710.82
Market Capitalization
Market Capitalization i₹3.10B₹1.69T
Enterprise Value i₹3.73B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i2.9315.86
Enterprise to EBITDA i-15.2448.63
Risk & Other Metrics
Beta i0.080.19
Book Value per Share (MRQ) i₹6.23₹580.95

Financial Statements Comparison: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKERALAYUR (2025)DIVISLAB (2025)
Revenue/Sales i1.19B93.25B
Cost of Goods Sold i249.68M38.70B
COGS % of Revenue i21.0%41.5%
Gross Profit i942.01M54.55B
Gross Margin i79.0%58.5%
Research & Development i1.26M270.00M
Operating Income (EBIT) i-99.66M25.71B
Operating Margin i-8.4%27.6%
EBITDA i-42.40M33.19B
EBITDA Margin i-3.6%35.6%
Pre-Tax Income i-122.36M29.16B
Pre-Tax Income % of Revenue i-10.3%31.3%
Income Tax i17.23M7.25B
Income Tax % of Revenue i1.4%7.8%
Net Income (Profit) i-139.59M21.91B
Profit Margin i-11.7%23.5%

Balance Sheet & Liquidity Metrics

MetricKERALAYUR (2025)DIVISLAB (2025)
Cash & Equivalents i33.89M4.15B
Total Current Assets i407.67M100.81B
Total Current Assets % of Revenue i34.2%108.1%
Total Current Liabilities i879.75M14.52B
Total Current Liabilities % of Revenue i73.8%15.6%
Long-Term Debt i222.20M20.00M
Long-Term Debt % of Revenue i18.6%0.0%
Total Shareholders Equity i-99.60M149.69B
Retained Earnings iN/A134.00B
Retained Earnings % of Revenue i0.0%143.7%
Property, Plant & Equipment i10.08M3.19B

Cash Flow Statement Comparison

MetricKERALAYUR (2025)DIVISLAB (2025)
Operating Cash Flow i43.75M19.67B
Operating Cash Flow % of Revenue i3.7%21.1%
Capital Expenditures i-133.20M-14.38B
Free Cash Flow i-84.95M2.15B
FCF Margin i-7.1%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKERALAYURDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i13.00M265.47M
Float Shares i6.30M117.72M
% Held by Insiders i52.41%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i47.59%19.31%

Dividend Analysis & Yield Comparison: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.

MetricKERALAYURDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025